九强生物: 关于九强转债转股价格调整的公告

Core Viewpoint - The company has announced an adjustment to the conversion price of its convertible bonds due to changes in its share capital structure following a cash dividend distribution [1][2][4]. Summary by Sections Conversion Price Adjustment Basis - The adjustment of the conversion price is based on the company's regulations regarding changes in share capital, including stock dividends, capital increases, and cash dividends [1][2]. Reason for Adjustment - The conversion price was adjusted because the company repurchased 3,544,084 shares that did not participate in the cash dividend distribution. The total cash dividend distributed was 174,829,363.20 yuan, calculated based on the number of shares participating in the distribution and the dividend per share of 0.30 yuan [2][3]. Result of Adjustment - The conversion price of the "Jiukang Convertible Bonds" will be adjusted from 16.98 yuan per share to 16.68 yuan per share, effective from September 5, 2025. This adjustment reflects the reduction in the cash dividend per share due to the repurchased shares [4].